Bausch + Lomb Corporation (BLCO) Covered Calls
Bausch + Lomb Corporation is a leading global eye health company that offers a comprehensive portfolio of products, including contact lenses, lens care solutions, ophthalmic pharmaceuticals, and surgical devices. Spun off from Bausch Health in 2022, the company serves patients and healthcare professionals in approximately 100 countries, focusing on protecting and enhancing the gift of sight.
You can sell covered calls on Bausch + Lomb Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BLCO (prices last updated Mon 4:16 PM ET):
| Bausch + Lomb Corporation (BLCO) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 17.22 | +0.16 | 16.89 | 18.00 | 435K | - | 6.0 |
| Covered Calls For Bausch + Lomb Corporation (BLCO) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 17 | 0.40 | 17.60 | -3.4% | -103.4% | |
| Apr 17 | 17 | 0.30 | 17.70 | -4.0% | -36.5% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Core Business and Products
Bausch + Lomb is a world-renowned brand in vision care and ophthalmology. The company operates in three main segments: Vision Care (contact lenses and consumer eye health), Pharmaceuticals (prescription medicines for glaucoma and dry eye), and Surgical (intraocular lenses and equipment). Its well-known consumer brands include Biotrue, Lumify, and PreserVision. The company’s integrated approach allows it to provide life-cycle solutions for eye health, from daily disposable lenses to advanced surgical platforms used in cataract and vitreoretinal procedures.
Competitive Landscape
The global eye health market is characterized by high barriers to entry and intense competition among specialized medical device and pharmaceutical firms. BLCO competes directly with several large, publicly traded companies. Key rivals with active options markets on major exchanges include Alcon Inc. and Johnson & Johnson, both of which have significant market share in vision care and surgical equipment. In the pharmaceutical and contact lens segments, it also faces competition from The Cooper Companies, Inc. and AbbVie Inc.. Despite its spin-off, its former parent Bausch Health Companies Inc. remains a significant stakeholder and strategic point of comparison.
Strategic Outlook and Innovation
The company’s strategic focus is on accelerating revenue growth through new product launches and expanding its presence in the fast-growing dry eye disease market. Innovation efforts are centered on its "Vision 27" program, which aims to improve operational efficiency and margin expansion. Key growth drivers include the continued uptake of Miebo and Xiidra in the prescription dry eye space and the development of next-generation silicone hydrogel contact lenses. The long-term outlook for BLCO depends on its ability to navigate a complex regulatory landscape while successfully competing against newer, tech-focused entrants in the digital health and eye care diagnostic sectors.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | CTMX covered calls | |
| 2. | SLV covered calls | 7. | EWZ covered calls | 2. | PATH covered calls | |
| 3. | EEM covered calls | 8. | GLD covered calls | 3. | KSS covered calls | |
| 4. | SPY covered calls | 9. | FXI covered calls | 4. | OWL covered calls | |
| 5. | IBIT covered calls | 10. | KWEB covered calls | 5. | USO covered calls | |
Want more examples? BLCN Covered Calls | BLD Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
